Cogent Biosciences

Compensation

Full Description

Who We Are: Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's. The company's lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS. Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights. The Role: We are seeking an experienced, collaborative, detail-oriented medical writer with a passion for medical writing. The successful candidate will lead the planning, authoring, reviewing, and QC of clinical and regulatory documents. The individual will work with cross-functional SMEs as well as independently to develop high-quality, scientifically accurate documents. In this role, the successful candidate will collaborate with and may oversee the work of contract writers. In addition, the candidate will contribute to medical writing process development. Responsibilities: • Employ scientific knowledge and analytical skills to author high-quality, scientifically accurate clinical and regulatory documents which may include clinical study protocols and amendments, clinical study reports, Investigator's brochures, common technical document modules, and briefing books • Facilitate document reviews and lead round-table meetings to achieve consensus among stakeholders on document content and strategy • Ensure consistent messaging across documents as appropriate • Represent the Medical Writing department on clinical study teams • Perform and/or manage quality control reviews of clinical and regulatory documents as needed • Collaborate with and manage contract writers as needed • Contribute to the development and implementation of medical writing processes • Adhere to regulatory standards and company SOPs • Perform other medical writing related duties as assigned Qualifications: • Bachelor's degree • Manager: 5+ years of medical writing experience; Sr. Manager: 7+ years of medical writing experience, or with fewer years of experience for individuals with an advanced degree [MS, PhD, MD, PharmD] • Strong knowledge of FDA and ICH guidelines, GCP, and applicable regulatory processes related to document preparation • Proficient in researching and understanding scientific literature and distilling complex topics clearly and accurately • Proficient in interpreting and critically analyzing data and summarizing it clearly and accurately • Strong project management and time management skills • Excellent interpersonal, written, and verbal communication skills • Self-motivated and effective in working with cross-functional teams • Strong computer and software skills (eg, Word, Excel, PowerPoint, Adobe suite, Veeva RIM, SharePoint) and ability to learn new computer applications • Experience as a key contributor or lead author for submissions of regulatory documents is preferred Salary Range: 130,000 - 180,000 $USD Target Bonus: 15% Exact compensation will vary based on skills, experience, and location. Our Locations Waltham, MA: Our Boston office includes an open office layout that has recently undergone a makeover designed for collaboration and giving our employees the best work place possible. Free access is provided for both on-site parking and gym facilities in the building. Boulder, CO: We have just moved into our new state-of-the art Research Facility in the fast-growing biopharmaceutical hub in the greater Denver/Boulder corridor. Our CEO is based full-time in this location and we are proud to call this the home of Cogent's discovery research organization. Our Offer To You To attract the very best talent, we offer a generous benefits package that includes competitive pay, performance-based bonus, stock options, insurance coverage (health, dental, life, and disability), competitive time-off, a 401(k) plan, and commuter/parking benefits. We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.